| Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia (NCT01013961) | ECOG-ACRIN Cancer Research Group | 2011-04-27 |
| Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer (NCT01212822) | Fox Chase Cancer Center | 2011-04-27 |
| Carboplatin and Bevacizumab for Recurrent Ependymoma (NCT01295944) | National Cancer Institute (NCI) | 2011-04-27 |
| Evaluation of Robot Assisted Neuro-Rehabilitation (NCT01253018) | VA Office of Research and Development | 2011-04-27 |
| A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT) (NCT01334918) | Astellas Pharma Inc | 2011-04-26 |
| Efficacy of Alitretinoin Treatment in Patients With Pustular Form of Psoriasis (NCT01245140) | Stiefel, a GSK Company | 2011-04-26 |
| Safety, Tolerability and Pharmacokinetics of SBC-102 (Sebelipase Alfa) in Adult Participants With Lysosomal Acid Lipase Deficiency (NCT01307098) | Alexion Pharmaceuticals, Inc. | 2011-04-25 |
| Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents (NCT01302847) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-20 |
| Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer (NCT01273610) | City of Hope Medical Center | 2011-04-20 |
| Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation (NCT01338987) | National Cancer Institute (NCI) | 2011-04-19 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children (NCT01323946) | GlaxoSmithKline | 2011-04-18 |
| Drosophila-generated CTL (NCT01271907) | National Cancer Institute (NCI) | 2011-04-15 |
| Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy (NCT01180959) | M.D. Anderson Cancer Center | 2011-04-14 |
| Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells (NCT01351025) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2011-04-14 |
| Intranasal SB-705498 in Allergic Rhinitis (AR) Patients (NCT01424397) | GlaxoSmithKline | 2011-04-14 |
| An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer (NCT01397305) | Isofol Medical AB | 2011-04-14 |
| Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer (NCT01220128) | GlaxoSmithKline | 2011-04-11 |
| YF476 and Type II Gastric Carcinoids (NCT02454075) | Trio Medicines Ltd. | 2011-04-11 |
| Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene (NCT01221077) | Astellas Pharma Inc | 2011-04-08 |
| Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal Cancer (NCT01298570) | UNC Lineberger Comprehensive Cancer Center | 2011-04-07 |
| Multiple Ascending Dose of BMS-911543 (NCT01236352) | Bristol-Myers Squibb | 2011-04-07 |
| Oral OKT3 for the Treatment of Active Ulcerative Colitis (NCT01287195) | Brigham and Women's Hospital | 2011-04-07 |
| Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's Disease (NCT01276509) | Shire | 2011-04-06 |
| Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer (NCT01267253) | Gynecologic Oncology Group | 2011-04-04 |
| PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities (NCT01325688) | Peplin | 2011-04-01 |
| A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuberculosis (TB) (NCT01241188) | Statens Serum Institut | 2011-04-01 |
| Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes (NCT01293461) | Cebix Incorporated | 2011-04-01 |
| A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3 (NCT01304524) | Inovio Pharmaceuticals | 2011-04-01 |
| Treatment Of Maxillary Bone Cysts With Autologous Bone Mesenchymal Stem Cells (MSV-H) (NCT01389661) | Red de Terapia Celular | 2011-04-01 |
| Panitumumab, Paclitaxel, Carboplatin and 5FU in the Treatment of Potentially Resectable Gastroesophageal Adenocarcinoma (NCT01182610) | Accelerated Community Oncology Research Network | 2011-04-01 |
| Single IV Administration of TB-402 for Prophylaxis of Venous Thromboembolic Events (VTE) After Total Hip Replacement Surgery (NCT01344954) | ThromboGenics | 2011-04-01 |
| Prevention of Propofol Injection Pain (NCT02203175) | Yeditepe University Hospital | 2011-04-01 |
| Bosutinib in Adult Patients With Recurrent Glioblastoma (NCT01331291) | Massachusetts General Hospital | 2011-04-01 |
| A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma (NCT01220271) | Eli Lilly and Company | 2011-04-01 |
| Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2 (NCT01200485) | M.D. Anderson Cancer Center | 2011-04-01 |
| Study of CG100649 Versus Celecoxib in Osteoarthritis Patients (NCT01341405) | CrystalGenomics, Inc. | 2011-04-01 |
| Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) (NCT01349192) | University of North Carolina, Chapel Hill | 2011-04-01 |
| Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen (NCT01332955) | ANRS, Emerging Infectious Diseases | 2011-04-01 |
| Sorafenib in Children and Young Adults With Recurrent or Progressive Low-Grade Astrocytomas (NCT01338857) | NYU Langone Health | 2011-04-01 |
| Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors (NCT01158118) | Washington University School of Medicine | 2011-04-01 |
| LAS41005 in Hyperkeratotic Actinic Keratosis (NCT01358851) | Almirall, S.A. | 2011-04-01 |
| Low Dose Arsenic Trioxide as a Potential Chemotherapy Protector (NCT01428128) | The University of Texas Health Science Center at San Antonio | 2011-04-01 |
| A Study to Investigate the Effect of SB-705498 on Chronic Cough (NCT01476098) | GlaxoSmithKline | 2011-04-01 |
| A PhaseⅡ Study: SOX vs SP in Adjuvant Chemotherapy After D2 Surgery (NCT01679340) | Peking University | 2011-04-01 |
| Study of Sildenafil Citrate on Insulin Resistance in African American (NCT01334554) | Vanderbilt University Medical Center | 2011-04-01 |
| Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia (NCT00962715) | M.D. Anderson Cancer Center | 2011-04-01 |
| Efficacy of Varenicline for Smokeless Tobacco Use in India (NCT01098305) | University of Pennsylvania | 2011-04-01 |
| Ganaxolone in Posttraumatic Stress Disorder (PTSD) (NCT01339689) | Marinus Pharmaceuticals | 2011-04-01 |
| A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG (NCT01242475) | Statens Serum Institut | 2011-04-01 |
| Study to Evaluate the Safety and Efficacy of IV Infusion Treatment With Omecamtiv Mecarbil in Subjects With Left Ventricular Systolic Dysfunction Hospitalized for Acute Heart Failure (ATOMIC-AHF) (NCT01300013) | Cytokinetics | 2011-04-01 |
| Reinitiation of Anticoagulation After Temporary Withdrawal of Vitamin K Antagonist (NCT01348074) | McMaster University | 2011-04-01 |
| Bee Venom Acupuncture for the Treatment of Chronic Low Back Pain (NCT01491321) | Kyunghee University Medical Center | 2011-04-01 |
| An Efficacy and Safety Study of Ha44 Gel Administered Topically for the Treatment of Head Lice Infestation (NCT01336647) | Dr. Reddy's Laboratories Limited | 2011-04-01 |
| NAM-Trial: Multiferon in Malignant Melanoma (NCT01341158) | University Hospital Tuebingen | 2011-04-01 |
| Study to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic Adenocarcinoma (NCT01233375) | Clovis Oncology, Inc. | 2011-04-01 |
| ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease (NCT01336088) | Addex Pharma S.A. | 2011-04-01 |
| A Study of TRK-170 for the Treatment of Crohn's Disease (NCT01345799) | Toray Industries, Inc | 2011-04-01 |
| Pediatric Pharmacokinetics And Safety Study Of Moxidectin (NCT01035619) | Pfizer | 2011-04-01 |
| Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide (NCT01282216) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-04-01 |
| Non-pharmacological Interventions for Preschoolers With Attention Deficit Hyperactivity Disorder (ADHD) (NCT01462032) | Queens College, The City University of New York | 2011-04-01 |
| Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia (NCT01256424) | Photocure | 2011-04-01 |
| IGEV Followed by Autologous Transplantation for Refractory or Relapsed Hodgkin Lymphoma (NCT01333605) | Fudan University | 2011-04-01 |
| A Mindfulness Meditation-Based Intervention for Younger Breast Cancer Survivors (NCT01558258) | Jonsson Comprehensive Cancer Center | 2011-04-01 |
| Efficacy and Safety of Qinbudan as an Adjunct Therapy for Retreatment Pulmonary Tuberculosis (NCT02313610) | Shanghai University of Traditional Chinese Medicine | 2011-04-01 |
| Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation (NCT01444131) | University of Stellenbosch | 2011-04-01 |
| Online Cognitive Behavioral Therapy (CBT) Workbook (NCT01337843) | Talaria, Inc | 2011-04-01 |
| Gluing Lacerations Utilizing Epinephrine (NCT01202487) | Children's Hospital of Eastern Ontario | 2011-04-01 |
| HYPAZ: Hypertension Induced by Pazopanib (NCT01392352) | Cambridge University Hospitals NHS Foundation Trust | 2011-04-01 |
| Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia (NCT01253070) | National Cancer Institute (NCI) | 2011-04-01 |
| A Study of 5-Azacitidine (Vidaza®) in Patients With Chronic Myelomonocytic Leukemia (NCT01350947) | University of Utah | 2011-04-01 |
| Cell Phone-supported Cognitive Behavioural Therapy (NCT01205191) | Linkoeping University | 2011-04-01 |
| MC-5A for Chemotherapy Induced Peripheral Neuropathy (NCT01261780) | University of Wisconsin, Madison | 2011-04-01 |
| Closing the Loop for 36 Hours in Adolescents With Type 1 Diabetes: Evaluation of Reduced Meal Bolusing (NCT01629251) | University of Cambridge | 2011-04-01 |
| Functional Electrical Stimulation (FES) Driven Stepping in Individuals With Spinal Cord Injury (NCT01479777) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2011-04-01 |
| A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes (NCT01674348) | Piramal Enterprises Limited | 2011-04-01 |
| Pharmacokinetics of Sulfadoxine-pyrimethamine Plus Amodiaquine for Intermittent Preventive Treatment in Children (IPTc) (NCT01328990) | London School of Hygiene and Tropical Medicine | 2011-04-01 |
| Long-Term Safety and Efficacy Study of Milnacipran in Pediatric Patients With Primary Fibromyalgia (NCT01331109) | Forest Laboratories | 2011-04-01 |
| Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion (NCT01976676) | National Nutrition and Food Technology Institute | 2011-04-01 |
| Acute Pain Study Following Bunionectomy (NCT01333722) | AbbVie (prior sponsor, Abbott) | 2011-04-01 |
| Building Complex Language (NCT01337232) | Governors State University | 2011-04-01 |
| A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain (NCT01345045) | AbbVie (prior sponsor, Abbott) | 2011-04-01 |
| Evaluation of Re-Entry Values and Mindfulness Program (REVAMP) With Jail Inmates (NCT01378923) | George Mason University | 2011-04-01 |
| Vigabatrin for Cocaine and Alcohol Dependence (NCT01335867) | University of Pennsylvania | 2011-04-01 |
| Assessment of Desogestrel in Ondine Syndrome (NCT01243697) | Assistance Publique - Hôpitaux de Paris | 2011-04-01 |
| Pharmacokinetic, Safety and Efficacy of Intermittent Application of Caspofungin for Antifungal Prophylaxis (NCT01318148) | Werner J. Heinz | 2011-04-01 |
| Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome (NCT01171378) | University of Oxford | 2011-04-01 |
| Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients (NCT01336062) | Peking University | 2011-04-01 |
| Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients (NCT01350362) | Noscira SA | 2011-04-01 |
| A Study to Evaluate the Safety of Long-term Treatment With Siltuximab in Patients With Multicentric Castleman's Disease (NCT01400503) | Janssen Research & Development, LLC | 2011-04-01 |
| Study of Ramucirumab or Icrucumab (IMC-18F1) With Docetaxel or Docetaxel Alone as Second-Line Therapy in Participants With Bladder,Urethra, Ureter, or Renal Pelvis Carcinoma (NCT01282463) | Eli Lilly and Company | 2011-04-01 |
| Comparison of the Efficacy and Tolerability of T1210 and Olopatadine Hydrochloride 0.1% in the Treatment of Seasonal Allergic Conjunctivitis (NCT01344083) | Laboratoires Thea | 2011-04-01 |
| Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI) (NCT01312935) | PolyMedix, Inc. | 2011-04-01 |
| Study of Ofatumomab in Combination With ICE-chemotherapy in Patients With Diffuse Large B-cell Lymphoma (DLBCL) (NCT02412267) | National Cancer Centre, Singapore | 2011-04-01 |
| Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases (NCT01336712) | Northside Hospital, Inc. | 2011-04-01 |
| Study of Inhaling Carbon Monoxide to Treat Patients With Intestinal Paralysis After Colon Surgery. (NCT01050712) | Queen's University | 2011-04-01 |
| Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD) (NCT01161628) | Northside Hospital, Inc. | 2011-04-01 |
| Study of Preoperative Weekly Paclitaxel and Carboplatin With Lapatinib (Tykerb®) in Patients With ErbB2-Positive Stage I-III Breast Cancer (NCT01309607) | National University Hospital, Singapore | 2011-04-01 |
| Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer (NCT01349933) | National Cancer Institute (NCI) | 2011-04-01 |
| Finding a Safe and Effective Dose of Linagliptin in Pediatric Patients With Type 2 Diabetes (NCT01342484) | Boehringer Ingelheim | 2011-04-01 |
| First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer (NCT01337154) | CytRx | 2011-04-01 |